Dashboard
Manage Tickers

NEO NEOGENOMICS INC

Nasdaq neogenomics.com


$ 9.94 $ -0.24 (-2.36 %)    

Tuesday, 28-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 633.55 $ 4.83 (0.77 %)
DIA $ 476.83 $ 1.80 (0.38 %)
SPY $ 687.33 $ 1.82 (0.27 %)
TLT $ 92.10 $ 0.24 (0.26 %)
GLD $ 364.95 $ -2.63 (-0.72 %)
$ 9.92
$ 10.82
$ 9.98 x 4
$ 11.00 x 25
$ 9.83 - $ 11.41
$ 4.72 - $ 19.12
8,763,051
na
1.28B
$ 1.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-28-2025 09-30-2025 10-Q
2 07-29-2025 06-30-2025 10-Q
3 04-29-2025 03-31-2025 10-Q
4 02-18-2025 12-31-2024 10-K
5 11-05-2024 09-30-2024 10-Q
6 07-30-2024 06-30-2024 10-Q
7 04-30-2024 03-31-2024 10-Q
8 02-20-2024 12-31-2023 10-K
9 11-06-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 02-24-2023 12-31-2022 10-K
13 11-08-2022 09-30-2022 10-Q
14 08-09-2022 06-30-2022 10-Q
15 05-09-2022 03-31-2022 10-Q
16 02-25-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-09-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-25-2021 12-31-2020 10-K
21 10-29-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 04-29-2020 03-31-2020 10-Q
24 02-28-2020 12-31-2019 10-K
25 11-13-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-08-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 11-06-2018 09-30-2018 10-Q
30 08-06-2018 06-30-2018 10-Q
31 05-08-2018 03-31-2018 10-Q
32 03-13-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
34 08-07-2017 06-30-2017 10-Q
35 05-09-2017 03-31-2017 10-Q
36 03-14-2017 12-31-2016 10-K
37 11-07-2016 09-30-2016 10-Q
38 08-05-2016 06-30-2016 10-Q
39 05-10-2016 03-31-2016 10-Q
40 03-15-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

earnings-scheduled-for-october-28-2025
Earnings Scheduled For October 28, 2025
10/28/2025 11:11:34

neogenomics-affirms-fy2025-adj-eps-guidance-of-008-012-vs-009-est
NeoGenomics Affirms FY2025 Adj EPS Guidanc...
10/28/2025 11:07:19

NeoGenomics (NASDAQ:NEO) affirms FY2025 Adj EPS guidance from $0.08-$0.12 to $0.08-$0.12 vs $0.09 analyst estimate..

neogenomics-q3-adj-eps-003-beats-002-estimate-sales-187797m-beat-183770m-estimate
NeoGenomics Q3 Adj. EPS $0.03 Beats $0.02 ...
10/28/2025 11:05:54

NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $0.02 by 4...

neogenomics-presents-assay-relevant-data-to-showcase-how-molecular-residual-disease-assay-may-benefit-pharma-partners-at-esmo-congress-2025
NeoGenomics Presents Assay-Relevant Data T...
10/14/2025 11:20:37

NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today annou...

neogenomics-stock-in-a-range-bound-matrix-weakness-likely-until-2026
NeoGenomics Stock In A Range-Bound Matrix,...
09/17/2025 11:58:59

Adhishthana.com analysis shows NeoGenomics has chosen the blue pill, consolidation likely to last until August 2026.

td-cowen-maintains-buy-on-neogenomics-raises-price-target-to-12
TD Cowen Maintains Buy on NeoGenomics, Rai...
09/12/2025 13:47:50

TD Cowen analyst Dan Brennan maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $10 to $12.

alibaba-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-tuesday
Alibaba To Rally More Than 12%? Here Are 1...
09/02/2025 12:05:01

stephens--co-maintains-overweight-on-neogenomics-raises-price-target-to-11
Stephens & Co. Maintains Overweight on Neo...
09/02/2025 11:35:00

Stephens & Co. analyst Mason Carrico maintains NeoGenomics (NASDAQ:NEO) with a Overweight and raises the price target fr...

4-analysts-assess-neogenomics-what-you-need-to-know
4 Analysts Assess NeoGenomics: What You Ne...
08/29/2025 19:01:47

needham-maintains-buy-on-neogenomics-raises-price-target-to-14
Needham Maintains Buy on NeoGenomics, Rais...
08/29/2025 18:27:44

Needham analyst Mike Matson maintains NeoGenomics (NASDAQ:NEO) with a Buy and raises the price target from $8 to $14.

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/29/2025 17:05:57

neogenomics-gains-unexpected-win-as-court-rejects-natera-claims
NeoGenomics Gains 'Unexpected' Win As Cour...
08/29/2025 17:04:10

NeoGenomics wins a North Carolina court ruling invalidating key Natera patents, clearing the way for its RaDaR ST assay and boo...

affirm-posts-better-than-expected-earnings-joins-ambarella-iren-petco-health-and-wellness-and-other-big-stocks-moving-higher-on-friday
Affirm Posts Better-Than-Expected Earnings...
08/29/2025 13:56:35

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/29/2025 12:07:49

neogenomics-secures-court-ruling-invalidating-nateras-patents-case-dismissed-with-prejudice
NeoGenomics Secures Court Ruling Invalidat...
08/29/2025 11:11:30

– NeoGenomics wins summary judgment in patent infringement lawsuit against Natera; Court rules Natera's patents are invalid...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

earnings-outlook-for-neogenomics
Earnings Outlook For NeoGenomics
08/11/2025 16:03:10

piper-sandler-maintains-overweight-on-neogenomics-lowers-price-target-to-11
Piper Sandler Maintains Overweight on NeoG...
08/04/2025 15:58:42

Piper Sandler analyst David Westenberg maintains NeoGenomics (NASDAQ:NEO) with a Overweight and lowers the price target from...

a-glimpse-into-the-expert-outlook-on-neogenomics-through-3-analysts
A Glimpse Into The Expert Outlook On NeoGe...
07/30/2025 18:00:30

morgan-stanley-maintains-equal-weight-on-neogenomics-lowers-price-target-to-8
Morgan Stanley Maintains Equal-Weight on N...
07/30/2025 15:32:25

Morgan Stanley analyst Tejas Savant maintains NeoGenomics (NASDAQ:NEO) with a Equal-Weight and lowers the price target from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION